We are live on ! Find out more
COCH icon

Envoy Medical
COCH

94 hedge funds and large institutions have $362M invested in Envoy Medical in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 7

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

9% more capital invested

Capital invested by funds: $331M → $362M (+$30.8M)

6.7% more ownership

Funds ownership: 80.61% → 87.31% (+6.7%)

6% more funds holding

Funds holding: 89 → 94 (+5)

Holders
94
Holders Change
+5
Holders Change %
+5.62%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
23
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$11.1M
2
MF
Magnetar Financial
Illinois
+$10.7M
3
Millennium Management
Millennium Management
New York
+$6.72M
4
DCM
Difesa Capital Management
New York
+$3.08M
5
HCM
Highbridge Capital Management
New York
+$2.95M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$9.06M
2
HI
HBK Investments
Texas
-$7.5M
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$3.52M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.94M
5
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
Janus Henderson Group
51
Janus Henderson Group
United Kingdom
$1.26M +$1.26M +128,194 New
AC
52
Athos Capital
Hong Kong
$983K – – –
RA
53
RiverPark Advisors
New York
$971K – – –
MTIM
54
Marathon Trading Investment Management
Pennsylvania
$970K – – –
Verition Fund Management
55
Verition Fund Management
Connecticut
$852K +$851K +86,665 New
AC
56
Ayrton Capital
Connecticut
$814K – – –
BFM
57
Boothbay Fund Management
New York
$732K – – –
AA
58
Ancora Advisors
Ohio
$715K – – –
CCM
59
CAAS Capital Management
New York
$699K – – –
Bank of Nova Scotia
60
Bank of Nova Scotia
Ontario, Canada
$688K – – –
SFM
61
Spartan Fund Management
Canada
$673K – – –
LCM
62
Lynwood Capital Management
Ontario, Canada
$623K – – –
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
$604K +$604K +61,474 New
SIM
64
Sandia Investment Management
Massachusetts
$596K – – –
KIM
65
Karpus Investment Management
New York
$570K – – –
PI
66
PEAK6 Investments
Illinois
$554K – – –
VF
67
Virtu Financial
New York
$543K +$542K +55,241 New
HF
68
HRT Financial
New York
$504K +$4.02K +409 +0.8%
PHAM
69
Portland Hill Asset Management
United Kingdom
$496K – – –
COPPSERS
70
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$491K – – –
HHGC
71
Hunting Hill Global Capital
New York
$491K – – –
OCAM
72
Owl Creek Asset Management
New York
$491K – – –
Blackstone Inc
73
Blackstone Inc
New York
$458K – – –
KTA
74
Keeley-Teton Advisors
Illinois
$456K -$11.5K -1,170 -2%
CM
75
Crestline Management
Texas
$433K +$432K +44,000 New
1 2
3
4 5

COCH Hedge Fund Activity: Q3 2022 in Review

94 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q3 2022, worth a combined $362M — up 9.3% from $331M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new COCH positions and 9 closed out — a net gain of 5 holders — while 23 added to existing stakes and 7 trimmed.

The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $11.1M. The largest seller was Goldman Sachs, cutting an estimated $9.06M.

  • 94 institutional investors held Envoy Medical (COCH) as of Q3 2022, up from 89 in Q2 2022.
  • Funds reported $362M of Envoy Medical stock for Q3 2022, up 9.3% quarter-over-quarter.
  • 14 funds opened new Envoy Medical positions in Q3 2022 and 9 closed out, a net change of +5 holders.
  • The largest Envoy Medical buyer in Q3 2022 was BNP Paribas Financial Markets, an estimated $11.1M added.
  • The largest Envoy Medical seller in Q3 2022 was Goldman Sachs, an estimated $9.06M sold.

Based on aggregated 13F filings for Q3 2022.